Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Pediatric Blood & Cancer|July 21, 2021
Transition care continuity promotes long-term retention in adult care among young adults with sickle cell diseaseKristen E Howell, Anjelica C Saulsberry-Abate, Joacy G Mathias, et al.
British Journal of Haematology|January 13, 2011
Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell diseaseKenneth I Ataga, Julia E Brittain, Susan K Jones, et al.
Intensive & Critical Care Nursing|December 17, 2022
Examining the needs of survivors of critical illness through the lens of palliative care: A qualitative study of survivor experiencesTammy L Eaton, Anna Lewis, Heidi S Donovan, et al.
British Journal of Haematology|February 18, 2011
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)Kenneth I Ataga, Marvin Reid, Samir K Ballas, et al.
British Journal of Haematology|October 30, 2015
Coagulation activation in sickle cell trait: an exploratory studyChirag Amin, Soheir Adam, Micah J Mooberry, et al.
Blood Advances|January 11, 2024
Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panelDeva Sharma, Ilknur Kozanoğlu, Kenneth I Ataga, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Blood|January 15, 2008
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaKenneth I Ataga, Wally R Smith, Laura M De Castro, et al.
Plos One|September 27, 2016
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell AnemiaKenneth I Ataga, Vimal K Derebail, Melissa Caughey, et al.
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Pageof 14